ITM_Logo_Claim_RGB_high-res.png
ITM to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 07, 2025 08:00 ET | ITM Isotope Technologies Munich SE
Garching / Munich, February 7, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in Oppenheimer’s 35th Annual Healthcare...
sns insider pvt ltd.png
Nuclear Medicine Market Size to Accumulate Around USD 38.8 Billion by 2032, Growing at a 15% CAGR - SNS Insider
February 05, 2025 09:30 ET | SNS Insider pvt ltd
Pune, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuclear Medicine Market Size & Growth Analysis: According to SNS Insider, The Global Nuclear Medicine Market size was valued at USD 11.1 billion in 2023...
ITM_Logo_Claim_RGB_high-res.png
ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
January 28, 2025 05:00 ET | ITM Isotope Technologies Munich SE
Phase 3 clinical trial with ITM-11 met its primary endpoint, demonstrating clinically relevant and statistically significant benefit in Progression-Free Survival (PFS) compared to everolimusITM plans...
DMR Logo.png
Global Radiopharmaceuticals Market is expected to reach revenue of USD 9,876.2 Mn by 2033, at 3.5% CAGR: Dimension Market Research.
January 20, 2025 10:29 ET | Dimension Market Research
New York, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Overview The Global Radiopharmaceuticals Market is expected to reach USD 7,225.6 Million by 2024 with further increases expected up until 2033, at an...
ITM_Logo_Claim_RGB_high-res.png
ITM and Ariceum Therapeutics Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
January 13, 2025 08:00 ET | ITM Isotope Technologies Munich SE
Garching / Munich / Berlin, Germany, January 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Ariceum Therapeutics (Ariceum), a private biotech...
GMILogo_Vertical-Gradient.png
Nuclear Medicine Market to hit USD 54.7 billion by 2032, says Global Market Insights Inc.
January 08, 2025 05:30 ET | Global Market Insights Inc.
Selbyville, Delaware, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Nuclear Medicine Market size reached USD 13.6 billion in 2023 and is poised for robust growth, with a projected CAGR of 16.3% from 2024 to...
plus_logo.png
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
December 03, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope Supply
plus_logo.png
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference
November 25, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference
plus_logo.png
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal Metastases
November 22, 2024 07:30 ET | Plus Therapeutics Inc.
Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay
factMR-logo.png
Optical Imaging Agent Market Expected to Expand at 8.1% CAGR, Reaching US$ 3,533.2 Million by 2034 | Fact.MR Report
November 21, 2024 07:30 ET | FACT.MR
Rockville, MD, Nov. 21, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global optical imaging agent market is estimated to reach a...